loader2
Partner With Us NRI

May 26, 2022


Category

Equity

AUM (Cr.)

4,851.32

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.78

Sharpe Ratio

2.89

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (Bonus) -7.68 -13.02 -9.45 22.42 17.45 20.02
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS -6.95 -7.57 4.33 13.69 10.25 11.08
Category Rank 3/8 5/8 9/8 6/8 8/8 8/8
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
SBI Banking & Financial Services Fund (G) 22.6493 2.42 -3.25 5.86 10.76 3,239.51 2.09 5,000.00 invest
Nippon India Banking&Financial Services (G) 333.6860 2.38 4.02 3.57 6.67 3,315.64 2.10 5,000.00 invest
Nippon India Banking&Financial Services (Bonus) 333.6860 2.38 4.02 3.57 6.67 3,315.64 2.10 5,000.00 invest
Mirae Asset Banking&Financial Services Fund (G) 11.3430 2.24 -1.66 0.00 0.00 994.71 0.00 5,000.00 invest
SBI Magnum Equity ESG Fund (IDCW) 46.0318 -89.17 4.27 11.00 10.73 4,272.22 2.11 1,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Apr 30, 2022 678.01 13.98 1.52
Equity-Cipla Apr 30, 2022 412.10 8.49 -3.62
Equity-Divi`s Lab. Apr 30, 2022 382.96 7.89 2.35
Equity-Dr Reddy`s Labs Apr 30, 2022 354.55 7.31 -3.81
Equity-Lupin Apr 30, 2022 320.20 6.60 -0.32
Equity-Torrent Pharma. Apr 30, 2022 297.65 6.14 0.80
Equity-Narayana Hrudaya Apr 30, 2022 290.01 5.98 -10.81
Equity-Abbott India Apr 30, 2022 243.45 5.02 -3.52
Equity-Aurobindo Pharma Apr 30, 2022 220.17 4.54 -5.91
Equity-Fortis Health. Apr 30, 2022 182.73 3.77 -8.01

latest news

Nippon India Passive Flexicap FOF Announces change in Fund Managers

Nippon India Mutual Fund has announced change in Fund Managers under Nippon...

May 17, 2022 09:46

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 May 2022 as the record date for d...

May 07, 2022 09:08

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 April 2022 as the record date for...

Apr 07, 2022 09:22

Nippon India Mutual Fund Announces merger of Nippon India Fixed Horizon Fund XXXIX Series 8 into Nippon India Short Term Fund

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 04, 2022 09:06

Nippon India Mutual Fund Announces merger of Nippon India Fixed Horizon Fund XXXX Series 15 into Nippon India Short Term Fund

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 02, 2022 09:43

Nippon India Mutual Fund Announces merger of under its schemes

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 01, 2022 10:25

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (Bonus)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com